Lead Medical Oncologists from the UK and India discuss new trial looking to reduce likelihood of cancer returning in operable patients undergoing treatment for colon cancer

FOxTROT 2 will be conducted across 12 hospitals in India that include sites within the NIHR Global Health Research Unit on Global Surgery network. The trial will look into the use of a short course of pre-operative (neoadjuvant) chemotherapy for old/ or frail patients due to undergo surgery for colon cancer, with the aim of the trail being to significantly decrease the likelihood of the cancer returning.

The meeting on the 19th July was lead by a Professor of Oncology based at the University of Leeds in the UK who is also the Lead Medical Oncologist for FOxTROT Trial Platform, and was Chaired by Professor Dhruva Ghosh (GSU India Hub Director). Also in attendance were various colleagues from across India and the UK that will be participating in this international project.

The online training session gave colleagues in attendance the chance to be taken through an overview of the of the trial and also discuss the Oncology requirements for FOxTROT, due to officially launch in the coming weeks. The online video provides insight for stakeholders within the arena of global surgery to gain an understanding of some of the topics that are key to discuss during the early stages of designing an international randomised trial.

You can find out more on the India Hub by clicking here.